US20160122765A1 - Qsox1 as an anti-neoplastic drug target - Google Patents

Qsox1 as an anti-neoplastic drug target Download PDF

Info

Publication number
US20160122765A1
US20160122765A1 US14/849,013 US201514849013A US2016122765A1 US 20160122765 A1 US20160122765 A1 US 20160122765A1 US 201514849013 A US201514849013 A US 201514849013A US 2016122765 A1 US2016122765 A1 US 2016122765A1
Authority
US
United States
Prior art keywords
qsox1
tumor
cells
expression
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/849,013
Inventor
Douglas Lake
Benjamin Katchman
Deborah Fass
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Arizona Board of Regents of ASU
Original Assignee
Yeda Research and Development Co Ltd
Arizona Board of Regents of ASU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US38450210P priority Critical
Priority to PCT/US2011/052122 priority patent/WO2012040095A1/en
Priority to US201261722396P priority
Priority to US13/847,930 priority patent/US8946186B2/en
Priority to US14/169,612 priority patent/US20140141015A1/en
Application filed by Yeda Research and Development Co Ltd, Arizona Board of Regents of ASU filed Critical Yeda Research and Development Co Ltd
Priority to US14/849,013 priority patent/US20160122765A1/en
Assigned to YEDA RESEARCH AND DEVELOPMENT CO. LTD. reassignment YEDA RESEARCH AND DEVELOPMENT CO. LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FASS, DEBORAH
Publication of US20160122765A1 publication Critical patent/US20160122765A1/en
Abandoned legal-status Critical Current

Links